These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4293335)

  • 21. [Lymphography in a case of retroperitoneal tuberculous lymphadenitis].
    Hirnle Z; Hirnlowa L; Kompoltowicz Z; Norkowska H; Kostecka-Pokryszko A
    Pol Tyg Lek; 1972 May; 27(20):758-9. PubMed ID: 5029669
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy of pulmonary tuberculosis with pneumoconiosis. Second report to the Medical Research Council from the Joint Investigators.
    Tubercle; 1967 Mar; 48(1):1-10. PubMed ID: 4227332
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 24. Rheumatoid syndrome during isoniazid therapy.
    Saslaw S; Klainer AS
    Am Rev Respir Dis; 1969 Aug; 100(2):221-3. PubMed ID: 5805265
    [No Abstract]   [Full Text] [Related]  

  • 25. [X-ray diagnosis of abdominal lymph node tuberculosis].
    Gotman LN
    Probl Tuberk; 1969; 47(7):55-8. PubMed ID: 5375121
    [No Abstract]   [Full Text] [Related]  

  • 26. [Viral hepatitis and pulmonary tuberculosis].
    Agraval PD
    Ter Arkh; 1975; 47(8):71-4. PubMed ID: 1237940
    [No Abstract]   [Full Text] [Related]  

  • 27. Prednisone as an adjunct in the chemotherapy of lymph node-bronchial tuberculosis in childhood: a double-blind study. II. Further term observation.
    Nemir RL; Cardona J; Vaziri F; Toledo R
    Am Rev Respir Dis; 1967 Mar; 95(3):402-10. PubMed ID: 5335164
    [No Abstract]   [Full Text] [Related]  

  • 28. Musculoskeletal tuberculosis.
    Kelly PJ; Karlson AG
    Mayo Clin Proc; 1969 Feb; 44(2):73-80. PubMed ID: 5764795
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA
    Probl Tuberk; 1967; 45(5):21-6. PubMed ID: 5617940
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM; Durante C; Ceicu A; el Fassi el Fahri M; Bahsoun H
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of treatment of pulmonary tuberculosis under conditions of compulsory isolation].
    Zaworski C
    Gruzlica; 1967 May; 35(5):441-5. PubMed ID: 6056258
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract]   [Full Text] [Related]  

  • 33. Focal pulmonary alveolar proteinosis in pulmonary tuberculosis.
    Steer A
    Arch Pathol; 1969 Mar; 87(3):347-52. PubMed ID: 5766260
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 36. The prognosis of pulmonary tuberculosis under modern treatment.
    Thomassen OK
    Scand J Respir Dis Suppl; 1968; 63():29-32. PubMed ID: 5188461
    [No Abstract]   [Full Text] [Related]  

  • 37. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 38. A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
    Cheung OT; Pugsley HE
    Can Med Assoc J; 1968 Jun; 98(25):1182-3. PubMed ID: 5657185
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.